IPRIPR2021-00816Final Written Decision
Regeneron Pharmaceuticals, Inc. et al.v.Novartis Pharma AG et al.
IPR challenge of US 9220631.
Type
IPR
Filed
Apr 16, 2021
Instituted
Oct 26, 2021
Decided
Nov 13, 2024
Patent
Application
13750352
Inventor
Juergen Sigg et al
Granted
Dec 29, 2015
01
Timeline
3 milestones
2021-04-16Petition filed
2021-10-26Institution
2022-10-25Terminated
02
Parties & counsel
Petitioner
Regeneron Pharmaceuticals, Inc. et al.
Counsel
Desai, Anishet al
Patent Owner
Novartis Pharma AG et al.
Counsel
Holland, Elizabethet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →